Messiou C - Search Results

1

Prospective Evaluation of Whole-Body MRI versus FDG PET/CT for Lesion Detection in Participants with Myeloma.

Messiou C, Porta N, Sharma B, Levine D, Koh DM, Boyd K, Pawlyn C, Riddell A, Downey K, Croft J, Morgan V, Stern S, Cheung B, Kyriakou C, Kaczmarek P, Winfield J, Blackledge M, Oyen WJG, Kaiser MF. Messiou C, et al. Radiol Imaging Cancer. 2021 Sep;3(5):e210048. doi: 10.1148/rycan.2021210048. Radiol Imaging Cancer. 2021. PMID: 34559006 Free PMC article.

2

Diffusion-weighted imaging in cervical cancer with an endovaginal technique: potential value for improving tumor detection in stage Ia and Ib1 disease.

Charles-Edwards EM, Messiou C, Morgan VA, De Silva SS, McWhinney NA, Katesmark M, Attygalle AD, DeSouza NM. Charles-Edwards EM, et al. Among authors: messiou c. Radiology. 2008 Nov;249(2):541-50. doi: 10.1148/radiol.2491072165. Radiology. 2008. PMID: 18936313

3

Diffusion weighted imaging of the uterus: regional ADC variation with oral contraceptive usage and comparison with cervical cancer.

Messiou C, Morgan VA, De Silva SS, Ind TE, deSouza NM. Messiou C, et al. Acta Radiol. 2009 Jul;50(6):696-701. doi: 10.1080/02841850902926473. Acta Radiol. 2009. PMID: 19449230

4

Imaging metastatic bone disease from carcinoma of the prostate.

Messiou C, Cook G, deSouza NM. Messiou C, et al. Br J Cancer. 2009 Oct 20;101(8):1225-32. doi: 10.1038/sj.bjc.6605334. Epub 2009 Sep 29. Br J Cancer. 2009. PMID: 19789531 Free PMC article. Review.

5

Optimising diffusion weighted MRI for imaging metastatic and myeloma bone disease and assessing reproducibility.

Messiou C, Collins DJ, Morgan VA, Desouza NM. Messiou C, et al. Eur Radiol. 2011 Aug;21(8):1713-8. doi: 10.1007/s00330-011-2116-4. Epub 2011 Apr 7. Eur Radiol. 2011. PMID: 21472473

6

Quantifying sclerotic bone metastases with 2D ultra short TE MRI: a feasibility study.

Messiou C, Collins DJ, Morgan VA, Robson MD, deBono JS, Bydder GM, deSouza NM. Messiou C, et al. Cancer Biomark. 2010;7(4):211-8. doi: 10.3233/CBM-2010-0189. Cancer Biomark. 2010. PMID: 21576814

7

Assessing response in bone metastases in prostate cancer with diffusion weighted MRI.

Messiou C, Collins DJ, Giles S, de Bono JS, Bianchini D, de Souza NM. Messiou C, et al. Eur Radiol. 2011 Oct;21(10):2169-77. doi: 10.1007/s00330-011-2173-8. Epub 2011 Jun 28. Eur Radiol. 2011. PMID: 21710270

8

Advanced solid tumors treated with cediranib: comparison of dynamic contrast-enhanced MR imaging and CT as markers of vascular activity.

Messiou C, Orton M, Ang JE, Collins DJ, Morgan VA, Mears D, Castellano I, Papadatos-Pastos D, Brunetto A, Tunariu N, Mann H, Tessier J, Young H, Ghiorghiu D, Marley S, Kaye SB, deBono JS, Leach MO, deSouza NM. Messiou C, et al. Radiology. 2012 Nov;265(2):426-36. doi: 10.1148/radiol.12112565. Epub 2012 Aug 13. Radiology. 2012. PMID: 22891356 Clinical Trial.

9

Assessing response of myeloma bone disease with diffusion-weighted MRI.

Messiou C, Giles S, Collins DJ, West S, Davies FE, Morgan GJ, Desouza NM. Messiou C, et al. Br J Radiol. 2012 Dec;85(1020):e1198-203. doi: 10.1259/bjr/52759767. Br J Radiol. 2012. PMID: 23175485 Free PMC article.

10

Use of apparent diffusion coefficient as a response biomarker in bone: effect of developing sclerosis on quantified values.

Messiou C, Collins DJ, Morgan VA, Bianchini D, de Bono JS, de Souza NM. Messiou C, et al. Skeletal Radiol. 2014 Feb;43(2):205-8. doi: 10.1007/s00256-013-1768-3. Epub 2013 Nov 24. Skeletal Radiol. 2014. PMID: 24271011 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

183 results

Search Page